All stock lists
Unlock the score
Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
Healthcare · Biotechnology
3.23-0.05 (-1.38%)
Insider Score
/ 100
RLMD Insider Score
RELMADA THERAPEUTICS, INC. has a live Insider Score.
Scored on 4 qualifying trades from 2 insiders in the last 90 days.
RLMD Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 6.62 M | 11.37 M | 12.26 M | 6.29 M | 7.40 M | 6.27 M |
| R&D Expense | 8.39 M | 8.09 M | 8.07 M | 4.04 M | 2.82 M | 11.95 M |
| Operating Expenses | 15.01 M | 19.46 M | 20.33 M | 10.33 M | 10.22 M | 18.22 M |
| Operating Income | -15.01 M | -19.46 M | -20.33 M | -10.33 M | -10.22 M | -18.22 M |
| Pretax Income | -12.91 M | -19.05 M | -19.87 M | -10.09 M | -9.87 M | -17.56 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -12.91 M | -19.05 M | -19.87 M | -10.09 M | -9.87 M | -17.56 M |
| EPS (Basic) | -0.11 | -0.22 | -0.29 | -0.30 | -0.30 | -0.58 |
| EPS (Diluted) | -0.11 | -0.22 | -0.29 | -0.30 | -0.30 | -0.58 |
| Shares Outstanding | 112.38 M | 86.60 M | 68.26 M | 33.19 M | 33.19 M | 30.41 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.